Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6- methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance

International Journal of Cancer

Volumn 80, Issue 5, 1999, Pages 744-750

  Lage, Hermann ^a   Christmann, Markus ^b   Kern, Monika A ^c   Dietel, Manfred ^a   Pick, Matthias ^b   Kaina, Bernd ^b   Schadendorf, Dirk ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNA GLYCOSYLTRANSFERASE; ETOPOSIDE; FOTEMUSTINE; METHYLTRANSFERASE; VINDESINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; DNA REPAIR; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CISPLATIN; DNA GLYCOSYLASES; DNA REPAIR; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE; ETOPOSIDE; HUMANS; MELANOMA; MUTS HOMOLOG 2 PROTEIN; N-GLYCOSYL HYDROLASES; NEOPLASM PROTEINS; NITROSOUREA COMPOUNDS; NUCLEAR PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; ORGANOPHOSPHORUS COMPOUNDS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VINDESINE;

EID: 0032922717     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990301)80:5<744::AID-IJC19>3.0.CO;2-5     Document Type: Article

References (29)

1. AEBI, S., FINK, D., GORDON, R., KIM, H.K., ZHENG, H., FINK, J.L. and HOWELL, S.B., Resistance to cytostatic drugs in DNA mismatch repair-deficient cells. Clin. Cancer Res., 3, 1763-1767 (1997).
2. AEBI, S., KURDI-HAIDAR, B., GORDON, R., CENNI, B., ZHENG, H., FINK, D., CHRISTEN, R.D., BOLAND, C.R., KOI, M., FISHEL, R. and HOWELL, S. B., Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res., 56, 3087-3090 (1996).
3. BRANCH, P., AQUILINA, G., BIGNAMI, M. and KARRAN, P., Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature (Lond.), 362, 652-654 (1993).
4. 2-acetylguanosine. Melanoma Res., 8, 123-130 (1998).
5. DOSCH, J., CHRISTMANN, M. and KAINA, B., Mismatch G-T binding activity and MSH2 expression are quantitatively related to sensitivity of cells to methylating agents. Carcinogenesis, 19, 567-573 (1998).
6. DRUMMOND, J.T., ANTHONEY, A., BROWN, R. and MODRICH, P., Cisplatin and adriamycin resistance are associated with MutL alpha and mismatch repair deficiency in an ovarian tumor cell line. J. Biol. Chem., 271, 19645-19648 (1996).
7. 6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours. Brit. J. Cancer, 71, 37-39 (1995).
8. ENGELWARD, B.P., DRESLIN, A., CHRISTENSEN, J., HUSZAR, D., KURAHARA, C. and SAMSON, L., Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J., 15, 945-952 (1996).
9. ESAKI, T., NAKANO, S., MASUMOTO, N., FUJISHIMA, H. and NIHO, Y., Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line. Int. J. Cancer, 65, 479-484 (1996).
10. FINK, D., AEBI, S. and HOWELL, S.B., The role of DNA mismatch repair in drug resistance. Clin. Cancer Res., 4, 1-6 (1998).
11. FINK, D., NEBEL, S., AEBI, S., ZHENG, H., CENNI, B., NEHMÈ, A., CHRISTEN, R.D. and HOWEEL, S.B., The role of DNA mismatch repair in platinum drug resistance. Cancer Res., 56, 4881-4886 (1996).
12. FRIEDMAN, H.S. and 15 OTHERS, Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res., 57, 2933-2936 (1997).
13. 2 cell cycle checkpoint. Cancer Res., 55, 3721-3725 (1995).
14. Ho, V.C. and SOBER, A.J., Therapy for cutaneous melanoma: an update. J. Amer. Acad. Dermatol., 22, 159-176 (1990).
15. IBEANU, G., HARTENSTEIN, B., DUNN, W.C., CHANG, L.Y., HOFFMANN, E., COQUERELLE, T., MITRA, S. and KAINA, B., Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. Carcinogenesis, 13, 1989-1995 (1992).
16. KAINA, B., HAAS, S. and KAPPES, H., A general role for c-Fos in cellular protection against DNA-damaging carcinogens and cytostatic drugs. Cancer Res., 57, 2721-2731 (1997).
17. KERN, M.A., HELMBACH, H., ARTUC, M., KARMANN, D., JURGOVSKY, K. and SCHADENDORF, D., Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. Anticancer Res., 17, 4359-4370 (1997).
18. 6-alkylguanine DNA-alkyltransferase in human liver and melanoma. Brit. J. Cancer, 66, 355-360 (1992).
19. 6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines. Cancer Res., 49, 4813-4817 (1989).
20. 6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int. J. Cancer, 65, 506-512 (1996).
21. QUINN, A.G., HEALY, E., REHMAN, I., SIKKINK, S. and REES, J.L., Microsatellite instability in human non-melanoma and melanoma skin cancer. J. invest. Dermatol., 104, 309-312 (1995).
22. SCHADENDORF, D., WORM, M., ALGERMISSEN, B., KOHLMUS, C.M. and CZARNETZKI, B.M., Chemosensitivity testing of human melanoma - a retrospective analysis of clinical response and in vitro drug sensitivity. Cancer, 73, 103-108 (1994).
23. TOMLINSON, I.P., BECK, N.E. and BODMER, W.F., Allele loss on chromosome 11q and microsatellite instability in malignant melanoma. Europ. J. Cancer, 32A, 1797-1802 (1996).
24. TONG, W.P., KOHN, K.W. and LUDLUM, D.B., Modifications of DNA by different haloethylnitrosoureas. Cancer Res., 42, 4460-4464 (1992).
25. WALKER, G.J., PALMER, J.M., WALTERS, M.K. and HAYWARD, N.K., A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromosomes Cancer, 12, 134-141 (1995).
26. 6-alkylguanine-DNA alkyltransferase activity. Brit. J. Cancer. 74, 1030-1036 (1996).
27. 6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model. Cancer Chemother. Pharmacol. 40, 266-272 (1997).
28. WEI, Q., GUAN, Y., CHENG, L., RADINSKY, R., BAR-ELI, M., TSAN, R., LI, L. and LEGERSKI, R.J., Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction. Pathobiology, 65, 293-300 (1997).
29. ZENG-RONG, N., PATERSON, J., ALPERT, L., TSAO, M.S., VIALLET, J. and ALAOUI-JAMALI, M.A., Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy. Cancer Res., 55, 4760-4764 (1995).